Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Surgery for emphysema: recent advances].

M Estenne1

  • 1Service de Pneumologie, Hôpital Erasme, Bruxelles, Belgique. mestenne@ulb.ac.be

Revue Des Maladies Respiratoires
|June 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cyclosporine A drives a Th17- and Th2-mediated posttransplant obliterative airway disease.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Percutaneous endoscopic jejunostomy in patients with gastroparesis following lung transplantation: feasibility and clinical outcome.

Endoscopy·2012
Same author

[Medical complications of lung transplantation].

Revue de pneumologie clinique·2011
Same author

[Complications of lung transplantation].

Revue des maladies respiratoires·2010
Same author

[Complications of lung transplantation: perioperative complications, acute and chronic rejection].

Revue des maladies respiratoires·2009
Same author

Paradoxical worsening of tuberculosis in a heart-lung transplant recipient.

Transplant infectious disease : an official journal of the Transplantation Society·2007
Same journal

[French version of the guidelines for connective tissue disease-associated ILD].

Revue des maladies respiratoires·2026
Same journal

[Pulmonary expression of an asymptomatic lysosomal storage disorder].

Revue des maladies respiratoires·2026
Same journal

[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy].

Revue des maladies respiratoires·2026
Same journal

[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].

Revue des maladies respiratoires·2026
Same journal

[Relevance of the ACT score in severe asthma with obesity: A pilot study].

Revue des maladies respiratoires·2026
Same journal

[Automated analysis of mandibular movements for the screening of obstructive sleep apnea].

Revue des maladies respiratoires·2026
See all related articles

For advanced chronic obstructive pulmonary disease (COPD), lung volume reduction surgery and lung transplantation offer significant benefits beyond traditional medical management. These advanced treatments improve quality of life and survival for carefully selected patients.

Area of Science:

  • Pulmonary Medicine
  • Thoracic Surgery

Context:

  • Chronic obstructive pulmonary disease (COPD) treatment has advanced significantly over 40 years.
  • Medical management offers limited benefits for advanced COPD, especially regarding quality of life.

Purpose:

  • To review developments in surgical treatments for emphysema, including lung volume reduction surgery (LVSR) and lung transplantation.
  • To discuss the role of LVSR and lung transplantation in managing advanced emphysema.

Summary:

  • Surgical options like LVSR and lung transplantation have emerged as viable treatments for carefully selected emphysema patients.
  • These procedures offer symptomatic improvement and potential for prolonged survival.
  • Extensive patient data has enhanced understanding of pathophysiology, techniques, risks, benefits, and selection criteria.

Related Experiment Videos

Impact:

  • Lung volume reduction surgery and lung transplantation represent significant progress in managing advanced emphysema.
  • These interventions provide hope for improved quality of life and survival for patients with severe COPD.